{"originalText": "，患者因“直肠癌”于2017-02-17在全麻上行直肠癌根治术(DIXON)，术后给予抗感染、营养支持、抑酸治疗，患者恢复好，切口愈合良好。，术后病理：直肠腺癌（中、低度分化），部分呈粘液腺癌分化，隆起型，体积9*9*2.5CM，侵穿浆膜，于外膜脂肪组织内查见一处癌转移灶。双端切线及另送“近切线”、“远切线”未查见癌。呈“一站”（1/12个）淋巴结癌转移。 “中央组”（2个）、“中间组”（1个）未查见癌。，免疫组化染色示：SYN（-）、BRAF（-）、MLH1（+）、MSH2（+）、MSH6（+）、PMS2（+）。 2017-03-17开始化疗，方案为奥沙利铂200MGD1，亚叶酸钙300MG+氟尿嘧啶750MG D2-D6，化疗期间有恶心、无呕吐，院外期间患者一般情况好，无恶心，无腹痛腹胀不适，现患者为行复查及化疗再次来院就诊，门诊以“直肠癌术后”收入院。   近期患者精神可，饮食可，大便次数多，小便正常，近期体重无明显变化。", "entities": [{"label_type": "疾病和诊断", "overlap": 0, "start_pos": 5, "end_pos": 8}, {"label_type": "手术", "overlap": 0, "start_pos": 25, "end_pos": 38}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 76, "end_pos": 102}, {"label_type": "解剖部位", "overlap": 0, "start_pos": 162, "end_pos": 175}, {"end_pos": 283, "label_type": "药物", "overlap": 0, "start_pos": 279}, {"end_pos": 295, "label_type": "药物", "overlap": 0, "start_pos": 291}, {"end_pos": 305, "label_type": "药物", "overlap": 0, "start_pos": 301}, {"end_pos": 347, "label_type": "解剖部位", "overlap": 0, "start_pos": 346}, {"end_pos": 349, "label_type": "解剖部位", "overlap": 0, "start_pos": 348}, {"label_type": "疾病和诊断", "overlap": 0, "start_pos": 374, "end_pos": 379}]}
